|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-9-23
|
|
pubmed:abstractText |
Our objective was to determine whether antibodies against the Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1), early antigen (EA), and EBV neutralizing antibodies (NeutAb) are altered in multiple sclerosis (MS).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1468-1331
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1263-9
|
|
pubmed:dateRevised |
2011-10-3
|
|
pubmed:meshHeading |
pubmed-meshheading:20402753-Adult,
pubmed-meshheading:20402753-Antibodies, Neutralizing,
pubmed-meshheading:20402753-Antigens, Viral,
pubmed-meshheading:20402753-Epstein-Barr Virus Infections,
pubmed-meshheading:20402753-Epstein-Barr Virus Nuclear Antigens,
pubmed-meshheading:20402753-Female,
pubmed-meshheading:20402753-Humans,
pubmed-meshheading:20402753-Male,
pubmed-meshheading:20402753-Middle Aged,
pubmed-meshheading:20402753-Multiple Sclerosis,
pubmed-meshheading:20402753-Multiple Sclerosis, Relapsing-Remitting
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.
|
|
pubmed:affiliation |
University of Texas Health Science Center at Houston, Houston, TX 77030, USA. John.w.lindsey@uth.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
